ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Cancer Centers Program To Implement Most Changes Sought By review Group

December 13, 1996

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980

Former Senator Cotton Named To NCA

April 11, 1975

Interview With AACR’s Margaret Foti: “The Meeting Wouldn’t Have Been The Same.”

April 4, 2003

Cancer Act Pulled Entire NIH Budget Up, Schmidt Says

July 20, 1984

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007